Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fazeel Siddiqui

Vascular Neurology Wyoming, MI Medical Doctor

NPI 1154513687 CMS profile 481855

5900 Byron Center Ave Sw, Wyoming, MI 49519

Open in the dashboard

General payments

$14,425

184 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$71,282 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Fazeel Siddiqui of Wyoming, MI is reported in the CMS Open Payments database as having received $14,425 across 184 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $71,282 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,096 52
2024 General $2,237 34
2023 General $2,948 32
2022 General $2,002 19
2021 General $863 14
2020 General $78 3
2019 General $2,202 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fazeel Siddiqui
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Fazeel Siddiqui were reported at $4,096. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Fazeel Siddiqui Vascular Neurology median Middle half National median
2019 $2,202 $263 $102–$1,640 $163
2020 $78 $153 $45–$1,000 $114
2021 $863 $261 $100–$1,355 $132
2022 $2,002 $242 $87–$1,273 $149
2023 $2,948 $322 $97–$1,266 $160
2024 $2,237 $247 $70–$1,053 $164
2025 $4,096 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $2,977 37 payments
  2. Penumbra, Inc. $2,460 46 payments
  3. Stryker Corporation $1,761 24 payments
  4. Terumo Medical Corporation $1,585 9 payments
  5. MicroVention, Inc. $1,204 16 payments
  6. Balt USA, LLC $947 10 payments
  7. Abbott Laboratories $873 12 payments
  8. Route 92 Medical, Inc. $861 3 payments
  9. Medical Device Business Services, Inc. $737 9 payments
  10. Imperative Care, INc $225 4 payments
  11. Other $795 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,486 159 payments
  2. Travel and Lodging $4,935 24 payments
  3. Gift $4 1 payment
Products named General payments · program years 2019–2025
  1. SOLITAIRE X $2,387 19 payments
  2. Penumbra System $1,786 18 payments
  3. GLIDESHEATH SLENDER $1,438 5 payments
  4. TREVO $846 10 payments
  5. Emboshield NAV6 system $846 10 payments
  6. TRUFILL $834 10 payments
  7. Optima Coil System $807 8 payments
  8. WEB $746 8 payments
  9. CEREPAK UNIFORM $737 9 payments
  10. EMBOTRAP $737 9 payments
  11. Other $6,317 127 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$21,679

Medicare's payments for the services billed

Medicare patients

43

Average age 70

Services billed

140

30 women, 13 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 58%
Ischemic heart disease 42%
Depression 35%
Chronic kidney disease 33%
Diabetes 26%
Heart failure 26%
Atrial fibrillation 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

184 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record